Atrial fibrillation other imaging findings: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(14 intermediate revisions by 6 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{| class="infobox" style="float:right;"
|-
| [[File:Siren.gif|30px|link=Atrial fibrillation resident survival guide]]|| <br> || <br>
| [[Atrial fibrillation resident survival guide|'''Resident'''<br>'''Survival'''<br>'''Guide''']]
|}
{| class="infobox" style="float:right;"
|-
| [[File:Critical_Pathways.gif|88px|link=Atrial fibrillation critical pathways]]|| <br> || <br>
|}
{| class="infobox" style="float:right;"
|-
| <small>Sinus rhythm</small> [[Image:Heart conduct sinus.gif|none|75px]]
| <small>Atrial fibrillation</small> [[Image:Heart conduct atrialfib.gif|none|100px]]
|}
{{Template:Atrial fibrillation}}
{{Template:Atrial fibrillation}}
{{CMG}}
{{CMG}} {{AE}} {{Anahita}}


==Ambulatory Holter monitoring==
==Overview==
Two other [[diagnosis|diagnostic studies]] include the [[Holter monitor]] to assess [[symptom|symptomatic]] episodes of [[atrial fibrillation]] over a 24 hour period and [[exercise stress testing]] to assess how [[patients]]' [[heart rate]] responds to [[exertion]]. The main benefits to performing an [[exercise stress test]] are to reproduce [[exertion|exercise]] induced [[atrial fibrillation]], and to exclude [[ischemia]] before initiating [[treatment]] with type 1C [[antiarrhythmic]] [[medications]].
 
==Other Imaging Studies==
===Ambulatory Holter Monitoring===
{{main|Holter monitor}}
{{main|Holter monitor}}
A [[holter monitor]] is a wearable ambulatory heart monitor that continuously monitors the heart rate and heart rhythm for a short duration, typically 24 hours. In individuals with symptoms of significant shortness of breath with exertion or palpitations on a regular basis, a holter monitor may be of benefit to determine if rapid heart rates (or unusually slow heart rates) during atrial fibrillation are the cause of the symptoms.
*A [[Holter monitor]] is a wearable ambulatory [[heart]] monitor that continuously monitors the [[heart rate]] and [[Sinus rhythm|heart rhythm]] for a short duration, typically 24 hours. <ref name="pmid16627441">{{cite journal| author=Vincenti A, Brambilla R, Fumagalli MG, Merola R, Pedretti S| title=Onset mechanism of paroxysmal atrial fibrillation detected by ambulatory Holter monitoring. | journal=Europace | year= 2006 | volume= 8 | issue= 3 | pages= 204-10 | pmid=16627441 | doi=10.1093/europace/euj043 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16627441  }} </ref>
*In individuals with [[symptoms]] of significant [[shortness of breath]] with [[exertion]] or [[palpitations]] on a regular basis, a [[Holter monitor]] may be of benefit to determine if [[Tachycardia|rapid heart rate]]s (or unusually [[bradycardia|slow heart rate]]s) during [[atrial fibrillation]] is the cause of the [[symptoms]].<ref name="pmid16627441">{{cite journal| author=Vincenti A, Brambilla R, Fumagalli MG, Merola R, Pedretti S| title=Onset mechanism of paroxysmal atrial fibrillation detected by ambulatory Holter monitoring. | journal=Europace | year= 2006 | volume= 8 | issue= 3 | pages= 204-10 | pmid=16627441 | doi=10.1093/europace/euj043 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16627441  }} </ref>
*Based on some experimental studies, longer duration of [[Holter monitoring]] (7 days) could be beneficial for [[patients]] with [[symptoms]] of cerebral ischemic events.<ref name="pmid20966415">{{cite journal| author=Stahrenberg R, Weber-Krüger M, Seegers J, Edelmann F, Lahno R, Haase B | display-authors=etal| title=Enhanced detection of paroxysmal atrial fibrillation by early and prolonged continuous holter monitoring in patients with cerebral ischemia presenting in sinus rhythm. | journal=Stroke | year= 2010 | volume= 41 | issue= 12 | pages= 2884-8 | pmid=20966415 | doi=10.1161/STROKEAHA.110.591958 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20966415  }} </ref><ref name="pmid18990460">{{cite journal| author=Dagres N, Kottkamp H, Piorkowski C, Weis S, Arya A, Sommer P | display-authors=etal| title=:Influence of the duration of Holter monitoring on the detection of arrhythmia recurrences after catheter ablation of atrial fibrillation: implications for patient follow-up. | journal=Int J Cardiol | year= 2010 | volume= 139 | issue= 3 | pages= 305-6 | pmid=18990460 | doi=10.1016/j.ijcard.2008.10.004 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18990460  }} </ref>


==Exercise stress testing==
===Exercise Stress Testing===
{{main|Cardiac stress test}}
{{main|Cardiac stress test}}
Some individuals with atrial fibrillation do well with normal activity but develop shortness of breath with exertion. It may be unclear if the shortness of breath is due to a blunted heart rate response to exertion due to excessive AV node blocking agents, a very rapid heart rate during exertion, or due to other underlying conditions such as chronic lung disease or coronary ischemia.  An [[cardiac stress test|exercise stress test]] will evaluate the individual's heart rate response to exertion and determine if the AV node blocking agents are contributing to the symptoms. As a summary the main benefits of performing an exercise stress testing;
*Some individuals with [[atrial fibrillation]] do well with normal activity but develop [[dyspnea|shortness of breath with [[exertion]].It may be unclear if the [[dyspnea|shortness of breath]] is due to a blunted [[heart rate]] response to [[exertion]] due to excessive [[Antiarrhythmic agent|AV node blocking agents]], a very [[rapid heart rate]] during [[exertion]], or due to other underlying conditions such as [[Chronic (medical)|chronic]] [[Respiratory disease|lung disease]] or [[ischemia|coronary ischemia]].<ref name="pmid20953841">{{cite journal| author=Nucifora G, Schuijf JD, van Werkhoven JM, Trines SA, Kajander S, Tops LF | display-authors=etal| title=Relationship between obstructive coronary artery disease and abnormal stress testing in patients with paroxysmal or persistent atrial fibrillation. | journal=Int J Cardiovasc Imaging | year= 2011 | volume= 27 | issue= 6 | pages= 777-85 | pmid=20953841 | doi=10.1007/s10554-010-9725-x | pmc=3144360 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20953841 }} </ref><ref name="pmid4590953">{{cite journal| author=Jelinek MV, Lown B| title=Exercise stress testing for exposure of cardiac arrhythmia. | journal=Prog Cardiovasc Dis | year= 1974 | volume= 16 | issue= 5 | pages= 497-522 | pmid=4590953 | doi=10.1016/0033-0620(74)90008-5 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=4590953  }} </ref>
 
*An [[cardiac stress test|exercise stress test]] will evaluate the individual's [[heart rate]] response to [[exertion]] and determine if the [[Antiarrhythmic agent|AV node blocking agents]] are contributing to the [[symptoms]].<ref name="pmid4590953">{{cite journal| author=Jelinek MV, Lown B| title=Exercise stress testing for exposure of cardiac arrhythmia. | journal=Prog Cardiovasc Dis | year= 1974 | volume= 16 | issue= 5 | pages= 497-522 | pmid=4590953 | doi=10.1016/0033-0620(74)90008-5 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=4590953  }} </ref>
*If the adequacy of rate control is in question (permanent AF)
*As a summary the main benefits of performing an [[exercise stress testing]] are:<ref name="pmid20953841">{{cite journal| author=Nucifora G, Schuijf JD, van Werkhoven JM, Trines SA, Kajander S, Tops LF | display-authors=etal| title=Relationship between obstructive coronary artery disease and abnormal stress testing in patients with paroxysmal or persistent atrial fibrillation. | journal=Int J Cardiovasc Imaging | year= 2011 | volume= 27 | issue= 6 | pages= 777-85 | pmid=20953841 | doi=10.1007/s10554-010-9725-x | pmc=3144360 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20953841  }} </ref>
*To reproduce exercise-induced AF
**If the adequacy of [[heart rate|rate]] control is in question ([[atrial fibrillation|permanent atrial fibrillation]])
*To exclude ischemia before treatment of selected patients with a type IC antiarrhythmic drug
**To reproduce [[Physical exercise|exercise]] induced [[atrial fibrillation]] ([[AF]])
**To exclude [[ischemia]] before [[treatment]] of selected [[patients]] with a type IC [[antiarrhythmic]] [[drug]]


==References==
==References==
{{reflist|2}}
{{reflist|2}}


{{Electrocardiography}}
{{WH}}
{{Circulatory system pathology}}
{{WS}}
[[CME Category::Cardiology]]


[[Category:Cardiology]]
[[Category:Up-To-Date]]
[[Category:Up-To-Date cardiology]]
[[Category:Arrhythmia]]
[[Category:Electrophysiology]]
[[Category:Electrophysiology]]
[[Category:Cardiology]]
[[Category:Disease]]
[[Category:Emergency medicine]]
[[Category:Emergency medicine]]
[[de:Vorhofflimmern]]
[[fr:Fibrillation auriculaire]]
[[it:Fibrillazione atriale]]
[[nl:Boezemfibrilleren]]
[[ja:心房細動]]
[[no:Atrieflimmer]]
[[pl:Migotanie przedsionków]]
[[ro:Fibrilaţia Atrială]]
[[fi:Eteisvärinä]]
[[zh:心房颤动]]
[[tr:Atriyal fibrillasyon]]
{{WH}}
{{WS}}

Latest revision as of 04:46, 25 October 2021



Resident
Survival
Guide
File:Critical Pathways.gif

Sinus rhythm
Atrial fibrillation

Atrial Fibrillation Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Atrial Fibrillation from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Special Groups

Postoperative AF
Acute Myocardial Infarction
Wolff-Parkinson-White Preexcitation Syndrome
Hypertrophic Cardiomyopathy
Hyperthyroidism
Pulmonary Diseases
Pregnancy
ACS and/or PCI or valve intervention
Heart failure

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

EKG Examples
A-Fib with LBBB

Chest X Ray

Echocardiography

Holter Monitoring and Exercise Stress Testing

Cardiac MRI

Treatment

Rate and Rhythm Control

Cardioversion

Overview
Electrical Cardioversion
Pharmacological Cardioversion

Anticoagulation

Overview
Warfarin
Converting from or to Warfarin
Converting from or to Parenteral Anticoagulants
Dabigatran

Maintenance of Sinus Rhythm

Surgery

Catheter Ablation
AV Nodal Ablation
Surgical Ablation
Cardiac Surgery

Specific Patient Groups

Primary Prevention

Secondary Prevention

Supportive Trial Data

Cost-Effectiveness of Therapy

Case Studies

Case #1

Atrial fibrillation other imaging findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Atrial fibrillation other imaging findings

CDC on Atrial fibrillation other imaging findings

Atrial fibrillation other imaging findings in the news

Blogs on Atrial fibrillation other imaging findings

Directions to Hospitals Treating Atrial fibrillation other imaging findings

Risk calculators and risk factors for Atrial fibrillation other imaging findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Anahita Deylamsalehi, M.D.[2]

Overview

Two other diagnostic studies include the Holter monitor to assess symptomatic episodes of atrial fibrillation over a 24 hour period and exercise stress testing to assess how patients' heart rate responds to exertion. The main benefits to performing an exercise stress test are to reproduce exercise induced atrial fibrillation, and to exclude ischemia before initiating treatment with type 1C antiarrhythmic medications.

Other Imaging Studies

Ambulatory Holter Monitoring

Exercise Stress Testing

References

  1. 1.0 1.1 Vincenti A, Brambilla R, Fumagalli MG, Merola R, Pedretti S (2006). "Onset mechanism of paroxysmal atrial fibrillation detected by ambulatory Holter monitoring". Europace. 8 (3): 204–10. doi:10.1093/europace/euj043. PMID 16627441.
  2. Stahrenberg R, Weber-Krüger M, Seegers J, Edelmann F, Lahno R, Haase B; et al. (2010). "Enhanced detection of paroxysmal atrial fibrillation by early and prolonged continuous holter monitoring in patients with cerebral ischemia presenting in sinus rhythm". Stroke. 41 (12): 2884–8. doi:10.1161/STROKEAHA.110.591958. PMID 20966415.
  3. Dagres N, Kottkamp H, Piorkowski C, Weis S, Arya A, Sommer P; et al. (2010). ":Influence of the duration of Holter monitoring on the detection of arrhythmia recurrences after catheter ablation of atrial fibrillation: implications for patient follow-up". Int J Cardiol. 139 (3): 305–6. doi:10.1016/j.ijcard.2008.10.004. PMID 18990460.
  4. 4.0 4.1 Nucifora G, Schuijf JD, van Werkhoven JM, Trines SA, Kajander S, Tops LF; et al. (2011). "Relationship between obstructive coronary artery disease and abnormal stress testing in patients with paroxysmal or persistent atrial fibrillation". Int J Cardiovasc Imaging. 27 (6): 777–85. doi:10.1007/s10554-010-9725-x. PMC 3144360. PMID 20953841.
  5. 5.0 5.1 Jelinek MV, Lown B (1974). "Exercise stress testing for exposure of cardiac arrhythmia". Prog Cardiovasc Dis. 16 (5): 497–522. doi:10.1016/0033-0620(74)90008-5. PMID 4590953.

Template:WH Template:WS CME Category::Cardiology